Advertisement
The leading life science news channel in the Nordic region.
Biotech Business - June 12, 2023
The company will invest 15.9 billion DKK starting in 2023 to expand an existing Active Pharmaceutical Ingredient (API) production facility in Denmark for the future portfolio within serious chronic diseases. The investment in Hillerød will create additional production capacity and increase Novo Nordisk’s ability to meet future market demands and be a key enabler for […]
Clinical Trials - June 12, 2023
Ultimovacs has announced the topline results of NIPU, an investigator-initiated Phase II trial in patients indicated for second-line treatment of malignant pleural mesothelioma (MPM). Based on central review, the study did not meet the primary endpoint of PFS. Investigator assessment of the primary endpoint, a pre-defined supportive analysis, showed a statistically significant positive PFS benefit […]
Event Highlights - June 10, 2023
On 26th April the Nordic Precision Medicine Forum landed in Stockholm for its seventh year, but this time it was bigger and better with the addition of the Nordic AI and Data in Medicine and Healthcare Forum and the Nordic Digital Health Forum. The conference, which was held at the impressive München Bryggeriet venue, was […]
PR Industry - June 9, 2023
Connect in Pharma announce today that for every visitor to the 2023 Geneva-based event, five Swiss francs will be donated to Global Health Security (GHS) Fund, a non-profit organisation driving local innovation and global programming to address threats to health security. Connect in Pharma, taking place 14 & 15 June 2023 in Geneva, brings together […]
Biotech Business - June 8, 2023
Mendus has entered into a manufacturing alliance with NorthX Biologics and has announced a directed share issue and a fully secured rights issue of units totaling approximately 317 million SEK in financing. In the alliance with NorthX, Mendus and NorthX will co-establish cell therapy manufacturing capabilities in Sweden, which will be used for late-stage development […]
Global report - June 8, 2023
This year’s BIO international Convention is back in Boston again after 5 years in other cities or going digital during the pandemic. Considering the number of attendees (at least 18,000 from 85 countries) and exhibiting companies in a fully packed exhibition area, it feels like BIO in Boston 2018, yet significantly different in some respects. […]
In a new job - June 7, 2023
XNK Therapeutics has announced the appointment of Hugo Petit as Chief Financial Officer (CFO) and member of the company’s leadership team. “We are very pleased to have Hugo join us as XNK’s new CFO. His wealth of financial experience, particularly in the life sciences sector, will strengthen the organization as we continue to grow the […]
Business - June 7, 2023
A reflection around the importance of aiming high in times of economic turmoil. Selling. Damn, it’s hard. Especially with capital markets going south. Business Development Professionals around the globe targeting biotech’s as their customer base would probably agree with me. We are all connected and the ripple effect of sharpened competition in raising capital is […]
Clinical Trials - June 7, 2023
FluoGuide has announced results from a phase IIa trial of its lead product FG001 in lung cancer. FG001 was shown to illuminate the majority of the patients’ lung tumors and was well tolerated in all patients. These results support further clinical development in this indication. FG001 was shown to light up lung cancer in 73% […]
Acquisition - June 6, 2023
Novo Nordisk has entered into exclusive negotiations for a controlling stake in Biocorp, which would be followed by a mandatory simplified tender offer on all remaining outstanding shares in the company at a price of 35 EUR per share in cash, representing a total equity value of approximately 154 million EUR. Biocorp is a French […]
This site uses cookies